# Qatar Diabetes Mobile Application Trial

> **NCT03998267** · NA · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 180 (estimated)

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DEVICE:** Droobi
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT03998267
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-22
- **Primary completion:** 2020-08-17
- **Final completion:** 2020-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998267, "Qatar Diabetes Mobile Application Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03998267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*